{
    "id": 26007,
    "fullName": "COX2 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "COX2 over exp indicates an over expression of the Cox2 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 4513,
        "geneSymbol": "COX2",
        "terms": [
            "COX2",
            "COII",
            "MTCO2"
        ]
    },
    "variant": "over exp",
    "createDate": "02/02/2017",
    "updateDate": "01/14/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9865,
            "approvalStatus": "Clinical Study - Cohort",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, high COX2 expression was associated with decreased colorectal adenoma development following chemopreventive treatment with Celebra (celecoxib) in patients at high risk for developing colorectal adenomas (RR, 0.37; 95% CI, 0.22-0.61; p=0.0001) (PMID: 29769213).",
            "molecularProfile": {
                "id": 27149,
                "profileName": "COX2 over exp"
            },
            "therapy": {
                "id": 2124,
                "therapyName": "Celecoxib",
                "synonyms": null
            },
            "indication": {
                "id": 50860,
                "name": "colorectal adenoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 7721,
                    "pubMedId": null,
                    "title": "Expression of COX-2 and 15-PGDH in adenomas removed during pretreatment colonoscopy to predict chemopreventive efficacy of the selective COX-2 inhibitor, celecoxib.",
                    "url": "http://meetinglibrary.asco.org/content/175867-195"
                },
                {
                    "id": 14600,
                    "pubMedId": 29769213,
                    "title": "Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29769213"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20617,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Clinoril (sulindac) treatment inhibited proliferation of COX2 overexpressing head and neck squamous cell carcinoma cells harboring PIK3CA mutations, including a cell line overxpressing PIK3CA H1047R in culture (PMID: 30683736).",
            "molecularProfile": {
                "id": 27149,
                "profileName": "COX2 over exp"
            },
            "therapy": {
                "id": 2126,
                "therapyName": "Sulindac",
                "synonyms": null
            },
            "indication": {
                "id": 5520,
                "name": "head and neck squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17965,
                    "pubMedId": 30683736,
                    "title": "Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30683736"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27149,
            "profileName": "COX2 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}